Mechanism
How EBC-46 Destroys Tumours: The PKC-δ Signalling Pathway Explained
Among the compounds emerging from rainforest-derived pharmacognosy research, tigilanol tiglate (EBC-46) stands out for its unusually rapid and localised antitumour effect. Within hours of direct intratumoural injection, observable tumour destruction occurs — a timeline that differs markedly from conventional chemotherapy. Understanding why requires examining the compound's interaction with the
